The findings from the U.S. Physician & Payer Forum report, “Accountable Care Organizations: How will Payer and Provider Adoption of This Model Impact Prescribing Trends in Asthma and COPD?” are based on survey results from 100 pulmonologists, 39 managed care organization pharmacy directors and two MCO medical directors.
According to the news release, the medical and drug savings from ACOs are expected to come from ACOs’ focus on prescribing lower-cost therapies, patient screenings and drug adherence.
More Articles on Accountable Care Organizations:
Via Christi Health Vying for Medicare ACO
9 Pioneer ACOs Could Back Out of Program
67% of Physicians Report No Personal Financial Benefit From ACOs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
